Kopran Limited has informed the Exchange about Submission of Draft Scheme of Amalgamation of Kopran Laboratories Limited (Transferor Company) with Kopran Limited (Transferee Limited) and their respective shareholders and creditors
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kopran Limited has submitted a Draft Scheme of Amalgamation to the Exchange for merging Kopran Laboratories Limited (Transferor Company) into Kopran Limited (Transferee Company). The amalgamation covers both companies and their respective shareholders and creditors. Specific share swap ratio, timeline, and financial details have not yet been disclosed in this announcement. The scheme will now proceed through further regulatory approvals, likely including NCLT.
This is an intra-group consolidation which may simplify the corporate structure. Shareholders should watch for the share swap ratio announcement and NCLT approval timeline, as the effective exchange ratio will determine any change in their economic interest. Short-term stock reaction is typically muted until ratio details are confirmed.